Article

Therapy switches in fingolimod-treated patients with multiple sclerosis: long-term experience from the German MS Registry.
Frahm, N. ORCID: https://orcid.org/0000-0002-4655-774X, Fneish, F. ORCID: https://orcid.org/0000-0001-8279-8463, Ellenberger, D. ORCID: https://orcid.org/0000-0002-2274-5025, Flachenecker, P., Paul, F. ORCID: https://orcid.org/0000-0002-6378-0070, Warnke, C. ORCID: https://orcid.org/0000-0002-3510-9255, Kleinschnitz, C., Parciak, T., Krefting, D., Hellwig, K., Haas, J., Rommer, P.S. ORCID: https://orcid.org/0000-0001-5209-6647, Stahmann, A. ORCID: https://orcid.org/0000-0001-5308-105X and Zettl, U.K.
Neurology and Therapy 11 (1): 319–336. March 2022

Network meta-analysis of food and drug administration-approved treatment options for adults with aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder.
Wingerchuk, D.M., Zhang, I., Kielhorn, A., Royston, M., Levy, M., Fujihara, K., Nakashima, I., Tanvir, I., Paul, F. ORCID: https://orcid.org/0000-0002-6378-0070 and Pittock, S.J. ORCID: https://orcid.org/0000-0002-6140-5584
Neurology and Therapy 11 (1): 123-135. March 2022

Review

Barriers in healthcare to the use of optical coherence tomography angiography in multiple sclerosis.
Reeß, L.G. ORCID: https://orcid.org/0009-0008-2571-0195, Salih, H., Delikaya, M., Paul, F. ORCID: https://orcid.org/0000-0002-6378-0070 and Oertel, F.C. ORCID: https://orcid.org/0000-0003-4906-5983
Neurology and Therapy 14 (1): 45-56. February 2025

Letter

A response to: Letter to the editor regarding "Network meta-analysis of food and drug administration-approved treatment options for adults with aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder".
Wingerchuk, D.M., Zhang, I., Kielhorn, A., Royston, M., Levy, M., Fujihara, K., Nakashima, I., Tanvir, I., Paul, F. ORCID: https://orcid.org/0000-0002-6378-0070 and Pittock, S.J. ORCID: https://orcid.org/0000-0002-6140-5584
Neurology and Therapy 2 July 2022